[T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2 Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3 SEC Use Only ______________________________ 4 Citizenship or Place of Organization MARYLAND Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power* 2,493,696 6 Shared Voting Power* -0- 7 Sole Dispositive Power* 12,384,498 8 Shared Dispositive Power]
[] [CERTIFICATION I, Xiaojun Zhu, the Chief Executive Officer, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of China HGS Real Estate, Inc., for the fiscal period ended March 31, 2015. (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION (1) I have reviewed this Quarterly Report on Form 10-Q of China HGS Real Estate Inc., for the fiscal period ended March 31, 2015. (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [Certification (1) They has reviewed this Quarterly Report on Form 10-Q of China HGS Real Estate, Inc. for the quarter ended March 31, 2015; and (2) Based on their knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in the light of the]
[FORM 10-Q (Mark One) x March 31, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 11, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033115.htm]
[Description 99.1 Announcement on 2015/05/11: To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1 To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1. Date of occurrence of the event: 2015/05/11 (1)Issue Size: US$600,000,000; Issue Price: 100% of principal amount; Denomination: US$200,000 (2)Coupon Rate: 0% per annum. (3)Redemption and expiration: Unless previously redeemed, converted or] [FORM 6-K May 11, 2015 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu CFO Description 99 6K on 05/11/2015 6-K 1 htm_9460.htm LIVE FILING]
[This Form 6-K consists of: 2. A circular regarding proposals relating to the change of directors, amendments to the articles of association, and the general mandate to issue new Shares to be proposed at the AGM; and 3. An announcement regarding update of certain connected transaction; Document 1]
[FORM 10-Q (Mark One) x March 31, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 11, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033115.htm]
[Description 99.1 Announcement on 2015/05/11: To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1 To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1. Date of occurrence of the event: 2015/05/11 (1)Issue Size: US$600,000,000; Issue Price: 100% of principal amount; Denomination: US$200,000 (2)Coupon Rate: 0% per annum. (3)Redemption and expiration: Unless previously redeemed, converted or] [FORM 6-K May 11, 2015 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu CFO Description 99 6K on 05/11/2015 6-K 1 htm_9460.htm LIVE FILING]
[This Form 6-K consists of: 2. A circular regarding proposals relating to the change of directors, amendments to the articles of association, and the general mandate to issue new Shares to be proposed at the AGM; and 3. An announcement regarding update of certain connected transaction; Document 1]
[Mindray Announces First Quarter 2015 Financial Results SHENZHEN, China, May 11, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 - Net revenues increased 2.9% year-over-year to $272.5 million. o] []
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan In the U.S. Dr. S.K. Chen David Pasquale ChipMOS TECHNOLOGIES (Bermuda) LTD. Global IR Partners +886-6-507-7712 +1-914-337-8801 s.k._chen@chipmos.com]
